Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$627,628,347
+$534,841,848 QoQ
Shares Held
11,193,657
+478.7% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RPRX ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
This page
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,628,347 | 11,193,657 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $92,786,499 | 1,934,261 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $47,659,387 | 1,233,421 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,366,058 | 1,030,784 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,986,436 | 277,189 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,388,383 | 269,463 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,286,862 | 246,447 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,099,398 | 286,299 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,131,819 | 270,452 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,948,740 | 261,730 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $38,431,445 | 1,368,154 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $54,035,793 | 1,991,002 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $70,530,347 | 2,294,416 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $89,208,369 | 2,475,947 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $98,979,104 | 2,504,532 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $94,134,105 | 2,342,810 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $98,900,865 | 2,352,542 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $88,096,313 | 2,261,199 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $90,760,726 | 2,277,559 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $79,390,039 | 2,196,736 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $90,171,974 | 2,199,853 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $102,690,989 | 2,354,218 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $160,618,207 | 3,209,155 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $346,280,273 | 8,231,050 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $389,490,967 | 8,022,471 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||